Biblio Discovery — Demo Discovery Service

91 results for "Issaka Sagara"

Showing 1–20 · 1.59 seconds · RSS

  1. Journal Article

    Magnitude and durability of ProC6C-AlOH/Matrix-Mtm vaccine-induced malaria transmission-blocking antibodies in Burkinabe adults from a Phase 1 randomized trial

    Mohammad Naghizadeh; Kazutoyo Miura; Ebenezer Addo Ofori et al.

    Human Vaccines & Immunotherapeutics, Vol. 21 No. 1 · 2025 · English · DOAJ Scopus

    ProC6C is a multi-stage malaria vaccine designed to disrupt parasite transmission and prevent infection by incorporating three parasite proteins (Pfs230-Pro, Pfs48/45-6C, and CSP) in a single vaccine antigen. The Phase 1 clinical trial (PACTR202201848463189) conducted in Burkina Faso, showed…

  2. Journal Article

    Impact of seasonal malaria chemoprevention on hospital admissions and mortality in children under 5 years of age in Ouelessebougou, Mali

    Djibrilla Issiaka; Amadou Barry; Tiangoua Traore et al.

    Malaria Journal, Vol. 19 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Background Seasonal malaria chemoprevention is widely implemented in Sahel and sub-Sahel countries in Africa. Few studies have assessed the impact of the SMC on hospital admission and death when it is implemented in the health system. This retrospective study assessed the impact of…

  3. Journal Article

    Delivery strategies for malaria vaccination in areas with seasonal malaria transmission

    Jayne Webster; Brian Greenwood; Daniel Chandramohan et al.

    BMJ Global Health, Vol. 8 No. 5 · 2023 · English · DOAJ Scopus

    Background Seasonal vaccination with the RTS,S/AS01E malaria vaccine given alongside seasonal malaria chemoprevention (SMC) substantially reduces malaria in young children. The WHO has recommended the use of RTS,S/AS01E, including seasonal vaccination, in areas with seasonal malaria transmission…

  4. Journal Article Full text

    Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial

    Amadou Barry; Djibrilla Issiaka; Tiangoua Traore et al.

    PLOS ONE, Vol. 13 No. 3 · 2018 · English · PLOS Scopus

    Background: Seasonal malaria chemoprevention (SMC), the administration of complete therapeutic courses of antimalarials to children aged 3–59 months during the malaria transmission season, is a new strategy recommended by the World Health Organization (WHO) for malaria control in Sahelian countries…

    Also available at: DOAJ

  5. Journal Article

    A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali

    Souleymane Dama; Hamidou Niangaly; Moussa Djimde et al.

    Malaria Journal, Vol. 17 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Background Artemether–lumefantrine (AL) and artesunate–amodiaquine are first-line treatment for uncomplicated malaria in many endemic countries, including Mali. Dihydroartemisinin–piperaquine (DHA–PQ) is also an alternative first-line artemisinin-based combination therapy, but only few…

  6. Journal Article

    Prevalence of malaria and factors associated with infection in children aged 6 months to 9 years in Guinea: Results from a national cross-sectional study

    Abdoul Habib Beavogui; Alexandre Delamou; Bienvenu Salim Camara et al.

    Parasite Epidemiology and Control, Vol. 11 · 2020 · English · DOAJ Scopus

    Worldwide, a child dies every two minutes due to malaria with Africa bearing about 90% of all malaria deaths particularly among children. This study aimed to describe malaria prevalence and its associated factors among children aged 6 months to 9 years in Guinea. We conducted a cross-sectional…

  7. Journal Article Full text

    Population impact of malaria control interventions in the health district of Kati, Mali

    Abdoulaye Katile; Issaka Sagara; Mady Cissoko et al.

    PLOS ONE, Vol. 19 No. 12 · 2024 · English · PLOS Scopus

    Background: WHO and its partners have adopted alternative control interventions since the failure to eradicate malaria worldwide in the 1960s and 1970s. The aim of these interventions has been to redesign the control interventions to make them more effective and more efficient. The purpose of this…

    Also available at: DOAJ

  8. Journal Article

    Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine

    Brian Greenwood; Alassane Dicko; Issaka Sagara et al.

    Malaria Journal, Vol. 16 No. 1 · 2017 · English · DOAJ Scopus

    Abstract In many parts of the African Sahel and sub-Sahel, where malaria remains a major cause of mortality and morbidity, transmission of the infection is highly seasonal. Seasonal malaria chemoprevention (SMC), which involves administration of a full course of malaria treatment to young children…

  9. Journal Article

    A human antibody epitope map of the malaria vaccine antigen Pfs25

    Niharika Shukla; Wai Kwan Tang; Camila H. Coelho et al.

    npj Vaccines, Vol. 8 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Pfs25 is a leading antigen for a malaria transmission-blocking vaccine and shows moderate transmission-blocking activity and induction of rapidly decreasing antibody titers in clinical trials. A comprehensive definition of all transmission-reducing epitopes of Pfs25 will inform…

  10. Journal Article

    “Spatial heterogeneity of environmental risk in randomized prevention trials: consequences and modeling”

    Abdoulaye Guindo; Issaka Sagara; Boukary Ouedraogo et al.

    BMC Medical Research Methodology, Vol. 19 No. 1 · 2019 · English · DOAJ Scopus

    Abstract Background In the context of environmentally influenced communicable diseases, proximity to environmental sources results in spatial heterogeneity of risk, which is sometimes difficult to measure in the field. Most prevention trials use randomization to achieve comparability between…

  11. Journal Article

    Genotypic analysis of Plasmodium falciparum malaria parasites in a clinical trial of RTS,S vaccination in combination with seasonal malaria chemoprevention

    Emily LaVerriere; Katrina Kelley; Alassane Dicko et al.

    Malaria Journal, Vol. 25 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Both vaccination and seasonal chemoprevention are effective interventions against malaria, but both morbidity and mortality due to malaria remain high, particularly in sub-Saharan Africa. A recent clinical trial showed that the combination of these interventions provided substantial…

  12. Journal Article Full text

    Impact of seasonal malaria chemoprevention timing on clinical malaria incidence dynamics in the Kedougou region, Senegal

    Betty Kazanga; El-Hadj Ba; Eva Legendre et al.

    PLOS Global Public Health, Vol. 5 No. 1 · 2025 · English · PLOS Scopus

    Seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine is recommended by the World Health Organization since 2012 for clinical malaria prevention in children in the Sahelian region of Africa. In Senegal, SMC implementation began in 2013 and is given to children under…

  13. Journal Article

    Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

    Juliana Inoue; Miguel Silva; Bakary Fofana et al.

    Emerging Infectious Diseases, Vol. 24 No. 8 · 2018 · English · DOAJ Scopus

    Dihydroartemisinin/piperaquine (DHA/PPQ) is increasingly deployed as an antimalaria drug in Africa. We report the detection in Mali of Plasmodium falciparum infections carrying plasmepsin 2 duplications (associated with piperaquine resistance) in 7/65 recurrent infections within 2 months after…

  14. Journal Article

    Impact of Control Interventions on Malaria Incidence in the General Population of Mali

    Mady Cissoko; Issaka Sagara; Abdoulaye Guindo et al.

    Journal of Epidemiology and Global Health, Vol. 15 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background The increase in malaria incidence and the reduction of funding for malaria control have highlighted the need to step up efforts in the fight against malaria in Mali. To further refine the malaria control strategy implemented in the country, this study aimed to evaluate the…

  15. Journal Article Full text

    Development and Qualification of an Antigen Integrity Assay for a Plasmodium falciparum Malaria Transmission Blocking Vaccine Candidate, Pfs230

    Kazutoyo Miura; Thao P. Pham; Shwu-Maan Lee et al.

    Vaccines, Vol. 10 No. 10 · 2022 · English · DOAJ Scopus

    During development of a subunit vaccine, monitoring integrity of the recombinant protein for process development and quality control is critical. Pfs230 is a leading malaria transmission blocking vaccine candidate and the first to reach a Phase 2 clinical trial. The Pfs230 protein is expressed on…

  16. Journal Article Full text

    Variation in Relative Abundance of Small Mammal Species Caught in Two Different Ecosystems and Implicated in the Spread of Emerging Pathogens in Mali

    Abdoulaye Kassoum Koné; Georges Diatta; Doumbo Safiatou Niare et al.

    Applied Sciences, Vol. 14 No. 20 · 2024 · English · DOAJ Scopus

    Background: Small rodents and insectivores are potential reservoirs of many pathogens transmissible to humans, such as bacteria, parasites and viruses responsible for epidemics in sub-Saharan Africa, particularly in West Africa. Few studies on small mammal species in West Africa are available. Our…

  17. Journal Article Full text

    Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay

    Kazutoyo Miura; Suwani Perera; Sarah Brockley et al.

    PLoS ONE, Vol. 6 No. 6 · 2011 · English · PLOS Scopus

    Background: Apical membrane antigen 1 (AMA1) is one of the best-studied blood-stage malaria vaccine candidates. When an AMA1 vaccine was tested in a malaria naïve population, it induced functionally active antibodies judged by Growth Inhibition Assay (GIA). However, the same vaccine failed to…